首页> 外文OA文献 >Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial

【2h】

Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial

机译：低剂量地高胰岛素Degludec 200单位/ mL每日一次可改善血糖控制，类似于初治2型糖尿病患者低血糖的低血糖风险的甘精胰岛素：为期26周的随机，对照，跨国，针对性治疗试用：BEGIN LOW VOLUME试用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Gough, SCL; Bhargava, A; Jain, R; Mersebach, H; Rasmussen, S; Bergenstal, RM;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种 aa
中图分类

相似文献

外文文献

1. Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial. [J] . Stephen C L Gough, Anuj Bhargava, Rajeev Jain, Diabetes care . 2013,第9期

机译：低剂量地高胰岛素Degludec 200单位/ mL每日一次可改善血糖控制，与初治2型糖尿病患者低血糖风险低的胰岛素甘精胰岛素相似：为期26周，随机，对照，多国，针对性治疗试用：BEGIN LOW VOLUME试用。
2. Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial. [J] . Stephen C L Gough, Anuj Bhargava, Rajeev Jain, Diabetes care . 2013,第9期

机译：低体积胰岛素Degludec 200单位/ ml每天一次改善血糖控制，与胰岛素 - 野患者2型糖尿病患者的低血糖风险低，有26周，随机，控制，跨国，治疗到目标试用：开始低卷试验。
3. Insulin degludec compared with insulin glargine in insulin-na?ve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial [J] . OnishiY., IwamotoY., YooS.J., Journal of diabetes investigation. . 2013,第6期

机译：未接受胰岛素治疗的2型糖尿病初发患者中胰岛素degludec与甘精胰岛素的比较：一项为期26周，随机，对照，泛亚治疗的靶向治疗试验
4. Randomised Controlled Trial of an In-Home Monitoring Intervention to Improve Health Outcomes for Type 2 Diabetes: Study Protocol [C] . Karen CARLISLE, Robin WARREN, Paul SCUFFHAM, Global Telehealth (Conference) . 2012

机译：随机对照试验的内部监测干预以改善2型糖尿病的健康结果：研究方案
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes [O] . Stephen C.L. Gough, Anuj Bhargava, Rajeev Jain, 2013

机译：低剂量的地高胰岛素Degludec 200单位/ mL每天一次可改善血糖控制类似于初治2型糖尿病患者的低血糖风险低的胰岛素甘精胰岛素
7. Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial [O] . ??? 2015

机译：门冬胰岛素/门冬胰岛素与门冬胰岛素30相比，亚洲2型糖尿病患者基础或前/自混胰岛素控制不当：一项为期26周的随机，治疗目标试验

Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial

著录项

相似文献

相关主题

期刊订阅